Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258362
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2005-11-22
Brief Title:
Carboplatin Docetaxel and Radiation Therapy in Treating Patients With Stage IIIIV or Recurrent Endometrial Cancer
Sponsor:
Masonic Cancer Center University of Minnesota
Organization:
Masonic Cancer Center University of Minnesota
Organization Data
Organization:
Masonic Cancer Center University of Minnesota
Class:
OTHER
Study ID:
2004LS021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Masonic Cancer Center University of Minnesota
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |